Literature DB >> 8856135

Effect of acute volume expansion associated with salt load on the profile of plasma angiotensins in rats.

A C Carvalho1, L M Botelho, L J Greene, R A Santos.   

Abstract

We measured the changes produced in renin and the peptide components of the circulating renin-angiotensin system by acute volume expansion alone or associated with salt load in rats. With both maneuvers, there was a decrease of plasma renin activity (PRA) and plasma angiotensin (Ang) concentrations, but the changes were more pronounced in the salt-load group. In contrasting to Ang I and Ang II, plasma Ang-(1-7) concentration decreased significantly only within 60 min of 5.0% NaCl infusion (19.5 +/- 2.9 vs 30.5 +/- 1.9 pg/ml in the control group). As expected, plasma vasopressin increased markedly in the animals submitted to acute salt load (144.0 +/- 42.0 vs 5.0 +/- 0.2 pg/ml in the control group). The dissociation between the changes in plasma Ang-(1-7) and that of other plasma angiotensins is consistent with our previous studies using chronic salt load, and suggests that during acute volume expansion associated with salt load Ang I is preferentially converted to Ang-(1-7). In contrast to vasopressin, however, plasma Ang-(1-7) concentration increased only after chronic salt load, suggesting that this angiotensin may be more involved with long-term mechanisms of control of hydromineral balance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856135     DOI: 10.1016/0162-3109(96)00030-6

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  2 in total

1.  Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.

Authors:  Elizabeth L Loreaux; Baksho Kaul; John N Lorenz; Jerry B Lingrel
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

2.  Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats.

Authors:  L Zambotti-Villela; S C Yamasaki; J S Villarroel; R F Alponti; P F Silveira
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.